Nomogram for Predicting Sepsis After Percutaneous Transhepatic Cholangioscopic Lithotripsy.

IF 4.2 2区 医学 Q2 IMMUNOLOGY
Journal of Inflammation Research Pub Date : 2025-05-13 eCollection Date: 2025-01-01 DOI:10.2147/JIR.S513678
Lve Cheng, Xiong Ding, Jie Liu, Mengjia Shi, Shijia Huang, Junwei Niu, Shengwei Li, Yao Cheng
{"title":"Nomogram for Predicting Sepsis After Percutaneous Transhepatic Cholangioscopic Lithotripsy.","authors":"Lve Cheng, Xiong Ding, Jie Liu, Mengjia Shi, Shijia Huang, Junwei Niu, Shengwei Li, Yao Cheng","doi":"10.2147/JIR.S513678","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Sepsis is a possible complication of percutaneous transhepatic cholangioscopic lithotripsy (PTCSL) for hepatolithiasis, but risk assessment tools are lacking. This study aimed to identify predictors of sepsis after PTCSL and develop a predictive nomogram.</p><p><strong>Patients and methods: </strong>In this nested case‒control study, the data from 298 patients who underwent 528 PTCSL sessions between 1 January 2016 and 1 July 2024 were retrospectively reviewed. All sessions demonstrating sepsis complications were included in the sepsis group. For each session in the sepsis group, two treatment date-matched sessions not demonstrating sepsis were randomly selected via a nested case‒control design. All the matched sessions were divided into training and validation sets. Least absolute shrinkage and selection operator (LASSO) analysis was conducted to preliminarily select predictors of sepsis complications. Multivariable logistic regression was performed to identify factors for constructing the nomogram.</p><p><strong>Results: </strong>Sepsis was diagnosed in 46 patients (53 sessions), for an incidence of 10.69% (53 among 496 sessions). Three characteristic variables were included in the model: operation technique (odds ratio [OR]=0.170, 95% confidence interval [CI]: 0.048-0.599, P=0.006), cirrhosis (OR=3.769, 95% CI: 1.474-9.638, P=0.006), and postoperative prophylactic dexamethasone (OR=0.267, 95% CI: 0.101-0.703, P=0.008). The area under the curve (AUC) for the nomogram was 0.756 (95% CI, 0.658-0.853) in the training set and 0.762 (95% CI, 0.618-0.906) in the validation set, demonstrating relatively high discriminability. The calibration curves demonstrated the consistency between the predicted and actual values. Decision curve analysis indicated that the nomogram offers net clinical benefits.</p><p><strong>Conclusion: </strong>The operation technique, cirrhosis, and postoperative prophylactic dexamethasone may predict the occurrence of sepsis after PTCSL. We developed a nomogram to predict sepsis complications following PTCSL and demonstrated its relatively strong performance.</p>","PeriodicalId":16107,"journal":{"name":"Journal of Inflammation Research","volume":"18 ","pages":"6203-6216"},"PeriodicalIF":4.2000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085138/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inflammation Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JIR.S513678","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Sepsis is a possible complication of percutaneous transhepatic cholangioscopic lithotripsy (PTCSL) for hepatolithiasis, but risk assessment tools are lacking. This study aimed to identify predictors of sepsis after PTCSL and develop a predictive nomogram.

Patients and methods: In this nested case‒control study, the data from 298 patients who underwent 528 PTCSL sessions between 1 January 2016 and 1 July 2024 were retrospectively reviewed. All sessions demonstrating sepsis complications were included in the sepsis group. For each session in the sepsis group, two treatment date-matched sessions not demonstrating sepsis were randomly selected via a nested case‒control design. All the matched sessions were divided into training and validation sets. Least absolute shrinkage and selection operator (LASSO) analysis was conducted to preliminarily select predictors of sepsis complications. Multivariable logistic regression was performed to identify factors for constructing the nomogram.

Results: Sepsis was diagnosed in 46 patients (53 sessions), for an incidence of 10.69% (53 among 496 sessions). Three characteristic variables were included in the model: operation technique (odds ratio [OR]=0.170, 95% confidence interval [CI]: 0.048-0.599, P=0.006), cirrhosis (OR=3.769, 95% CI: 1.474-9.638, P=0.006), and postoperative prophylactic dexamethasone (OR=0.267, 95% CI: 0.101-0.703, P=0.008). The area under the curve (AUC) for the nomogram was 0.756 (95% CI, 0.658-0.853) in the training set and 0.762 (95% CI, 0.618-0.906) in the validation set, demonstrating relatively high discriminability. The calibration curves demonstrated the consistency between the predicted and actual values. Decision curve analysis indicated that the nomogram offers net clinical benefits.

Conclusion: The operation technique, cirrhosis, and postoperative prophylactic dexamethasone may predict the occurrence of sepsis after PTCSL. We developed a nomogram to predict sepsis complications following PTCSL and demonstrated its relatively strong performance.

经皮经肝胆道镜碎石术后脓毒症的Nomogram预测方法。
目的:脓毒症是经皮经肝胆管镜碎石术(PTCSL)治疗肝内结石的可能并发症,但缺乏风险评估工具。本研究旨在确定PTCSL后脓毒症的预测因素,并制定预测图。患者和方法:在这项巢式病例对照研究中,回顾性分析了2016年1月1日至2024年7月1日期间接受528次PTCSL治疗的298名患者的数据。所有出现脓毒症并发症的疗程都被纳入脓毒症组。对于脓毒症组的每个疗程,通过嵌套病例对照设计随机选择两个治疗日期匹配的未显示脓毒症的疗程。所有匹配的会话被分为训练集和验证集。进行最小绝对收缩和选择算子(LASSO)分析,初步选择脓毒症并发症的预测因素。采用多变量逻辑回归来确定构建模态图的因素。结果:46例患者(53例)被诊断为脓毒症,发生率为10.69%(496例中53例)。模型纳入三个特征变量:手术技术(优势比[OR]=0.170, 95%可信区间[CI]: 0.048 ~ 0.599, P=0.006)、肝硬化(OR=3.769, 95% CI: 1.474 ~ 9.638, P=0.006)、术后预防性地塞米松(OR=0.267, 95% CI: 0.101 ~ 0.703, P=0.008)。训练集的曲线下面积(AUC)为0.756 (95% CI, 0.658-0.853),验证集的AUC为0.762 (95% CI, 0.618-0.906),具有较高的判别性。标定曲线表明预测值与实测值基本一致。决策曲线分析表明,nomographic提供了净临床效益。结论:手术技术、肝硬化、术后预防性地塞米松可预测PTCSL术后脓毒症的发生。我们开发了一种预测PTCSL后脓毒症并发症的nomogram,并证明了其相对较强的性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Inflammation Research
Journal of Inflammation Research Immunology and Microbiology-Immunology
CiteScore
6.10
自引率
2.20%
发文量
658
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信